Juliette Foucher published her first thesis paper

The Summer 2023 brought to the amyotrophic lateral sclerosis (ALS) Swedish community the validation of a neuropsychological tool in the Swedish language.

Juliette Foucher, from Caroline Ingre's research group at the Department of Clinical Neuroscience, published her first thesis paper validating the Edingburgh Cognitive and Behavioral ALS Screen (ECAS) in Swedish. The ECAS is a tool that allows to evaluate and monitor cognitive and behavioral changes that occur in up to 50% of ALS patients. ALS was for a long time considered to be purely a muscle disease, but scientists are now showing that people living with ALS often develop cognitive and behavioral symptoms, highlighting the need to have validated tools to be used both in clinic and in research settings. If the ECAS was prevously translated in Swedish it had never been validated, meaning the reliability of the tool had not been assessed and confirmed in the Swedish language. Thanks to the collection of the ECAS since 2017 within Caroline Ingre's team, Juliette was able to validate it and confirm that the test was performant in differencitating between cognitive impairment or unimpairment.

The full article is available in Open access via this link: https://pubmed.ncbi.nlm.nih.gov/37519256/